Infectious Diseases News and Research

RSS

Dynavax Technologies announces first clinical data for HEPLISAV investigational hepatitis B vaccine

Dynavax Technologies Corporation today announced the first clinical data for HEPLISAVTM investigational hepatitis B vaccine in chronic kidney disease patients.

30 Oct 2009

Risk of serious flu-related sickness far outpaces risk of injectable vaccine in pregnant women

Pregnant women who catch the flu are at serious risk for flu-related complications, including death, and that risk far outweighs the risk of possible side effects from injectable vaccines containing killed virus, according to an extensive review of published research and data from previous flu seasons.

30 Oct 2009

Cempra Pharmaceuticals to present CEM-102 data at the Infectious Diseases Society of America meeting

Cempra Pharmaceuticals today announced data presentations of its lead antibiotic candidate, CEM-102 (fusidic acid), at the Infectious Diseases Society of America, 47th Annual Meeting, Oct. 29 to Nov. 1, 2009, in Philadelphia.

29 Oct 2009

AAHP updates about the sale of homeopathic medicines to prevent the flu

Recent news articles regarding the scarcity of the "flu shot" (or influenza inoculations) have been widespread. The shortage of the material, due to manufacturing and regulatory issues, has led to increased interest in homeopathic Influenzinum.

29 Oct 2009

Cempra Pharmaceuticals stages a presentation on CEM-101

Cempra Pharmaceuticals today announced a presentation on its novel fluoroketolide antibiotic, CEM-101, at the Infectious Diseases Society of America, 47th Annual Meeting, October 29 to November 1, 2009, in Philadelphia.

29 Oct 2009

AAHP confirms homeopathic medicines for prophylaxis of infectious diseases

Recent news articles regarding Swine Flu H1N1 have been widespread. The virulence of the strain among humans and its implications for pandemic disease in humans may lead to increased interest in homeopathic treatments for Swine Flu H1N1.

29 Oct 2009

NIH awards contract to LRRI for anthrax research

Lovelace Respiratory Research Institute (LRRI) was recently awarded a contract to continue research due to the potential for bioterrorist attacks involving Bacillus anthracis, the causative agent of anthrax, by the National Institutes of Allergy and Infectious Disease (NIAID), a division of the National Institutes of Health (NIH).

29 Oct 2009

$12.2 million grant from NIH for research on the sexually transmitted bacteria chlamydia

Perhaps the most comprehensive, multi-institutional study yet of the sexually transmitted bacteria chlamydia is under way at the University of Maryland, Baltimore (UMB).

29 Oct 2009

NIH awards Excelimmune grant to develop treatment for Clostridium difficile infection

Excelimmune, Inc. (www.excelimmune.com) announced today that the National Institutes of Health (NIH) has awarded the company a Small Business Innovation Research (SBIR) grant to support research aimed at developing new treatments for Clostridium difficile (C. difficile) infection, employing Excelimmune’s expertise in developing novel antibody therapies for human disease.

28 Oct 2009

WHO identifies five major causes of premature death

Targeting the five major causes of premature death could increase global life expectancy by almost five years, the WHO said Tuesday, Reuters reports. According to a WHO's Global Health Risks report, which looked at 24 major health risks, "[p]oor childhood nutrition, unsafe sex, alcohol, bad sanitation and hygiene, and high blood pressure are to blame for around a quarter of the 60 million premature deaths around the world each year," the news service writes.

28 Oct 2009

Micronics inks license agreement with Biosearch Technologies

Micronics, Inc., a leading developer of point-of-care molecular diagnostic products, announced today that it has entered into a license agreement with Biosearch Technologies, Inc. (Biosearch) for the right to make, have made, use and sell Micronics’ products that incorporate Biosearch’s proprietary fluorophores and quencher dyes for nucleic acid assays. Under the terms of the worldwide license, Biosearch has granted Micronics a royalty-free use of certain of its chemistries for inclusion in Micronics’ infectious disease tests for sale in underdeveloped countries.

28 Oct 2009

Veeva CRM to be implemented at Adamas Pharmaceuticals

Adamas Pharmaceuticals, an emerging pharmaceutical company focused on developing small-molecule therapeutics to treat neurological and infectious diseases, selected Veeva System’s VBioPharma™ KOL Edition – part of the Veeva CRM suite. Selection of Veeva’s SaaS solution marks an important step in Adamas’ early-stage product commercialization strategy.

28 Oct 2009

Innovative new partnership to provide free HIV testing and HIV/AIDS medical care in Saint-Petersburg

AIDS Healthcare Foundation (AHF), Saint-Petersburg Government Healthcare Institution’s Center for Prevention and Control of Infectious Diseases; AIDS, Statistics, Health, a respected regional non-governmental organization (NGO); and Saint-Petersburg Government Healthcare Institution’s Policlinic N109 are honored to announce that they are forming an innovative new partnership to provide free HIV testing and prevention services and HIV/AIDS medical care in Saint-Petersburg, Russia’s second largest city.

28 Oct 2009

Drug-cocktail approach offers hope in developing single agent to treat drug-resistant H1N1 swine flu

An experimental drug cocktail that includes three prescriptions now widely available offers the best hope in developing a single agent to treat drug-resistant H1N1 swine flu, says a virology researcher in the University of Alabama Birmingham (UAB) Division of Pediatric Infectious Diseases.

28 Oct 2009

HMSMobile Swine Flu Center application to provide information on H1N1 virus introduced

The HMSMobile Swine Flu Center, a new iPhone application developed by the Harvard Health Publications Division of Harvard Medical School, is now available for purchase in the iTunes store.

28 Oct 2009

Roche's high-throughput sequencing technology used for high-resolution HLA genotyping

A study published this month in the journal Tissue Antigens reports that researchers at Roche Molecular Systems in Pleasanton, CA have used high-throughput sequencing technology from 454 Life Sciences, a Roche Company, to carry out high-resolution human leukocyte antigen (HLA) genotyping in research samples.

27 Oct 2009

OrSense launches a non-invasive Hb measurement system for anemia screening

OrSense Ltd., developer of monitors for non-invasive measurements of various blood parameters, announced today at the American Association of Blood Banks (AABB) Annual Meeting & TXPO, at New Orleans, the presentation of NBM-200, a non-invasive hemoglobin (Hb) measurement system for anemia screening in blood donation centers.

27 Oct 2009

Climate change and public health: only fives states have published public health response plans, says study

Trust for America's Health (TFAH) released a new report today that finds only five states have published a strategic climate change plan that includes a public health response. This includes planning for health challenges and emergencies expected to develop from natural disasters, pollution, and infectious diseases as temperatures and sea levels rise.

27 Oct 2009

PolyMedix completes second successful clinical study of PMX-60056

PolyMedix, Inc. (http://polymedix.com), an emerging biotechnology company developing new therapeutic drug products to treat infectious diseases and acute cardiovascular disorders, has completed a second successful clinical study of its anticoagulant reversing agent, PMX-60056.

27 Oct 2009

Vaccination rates need improvement; racial and ethnic disparities in vaccination coverage

More teenagers are being vaccinated against human papillomavirus (HPV), meningococcal meningitis and pertussis (whooping cough), though the rates are still too low, according to recently released government data and a panel of experts convened by the National Foundation for Infectious Diseases (NFID).

27 Oct 2009

Infectious Diseases News and Research

Dynavax Technologies announces first clinical data for HEPLISAV investigational hepatitis B vaccine

Risk of serious flu-related sickness far outpaces risk of injectable vaccine in pregnant women

Cempra Pharmaceuticals to present CEM-102 data at the Infectious Diseases Society of America meeting

AAHP updates about the sale of homeopathic medicines to prevent the flu

Cempra Pharmaceuticals stages a presentation on CEM-101

AAHP confirms homeopathic medicines for prophylaxis of infectious diseases

NIH awards contract to LRRI for anthrax research

$12.2 million grant from NIH for research on the sexually transmitted bacteria chlamydia

NIH awards Excelimmune grant to develop treatment for Clostridium difficile infection

WHO identifies five major causes of premature death

Micronics inks license agreement with Biosearch Technologies

Veeva CRM to be implemented at Adamas Pharmaceuticals

Innovative new partnership to provide free HIV testing and HIV/AIDS medical care in Saint-Petersburg

Drug-cocktail approach offers hope in developing single agent to treat drug-resistant H1N1 swine flu

HMSMobile Swine Flu Center application to provide information on H1N1 virus introduced

Roche's high-throughput sequencing technology used for high-resolution HLA genotyping

OrSense launches a non-invasive Hb measurement system for anemia screening

Climate change and public health: only fives states have published public health response plans, says study

PolyMedix completes second successful clinical study of PMX-60056

Vaccination rates need improvement; racial and ethnic disparities in vaccination coverage

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News